Copaxone in Age Related Macular Degeneration
NCT00466076
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
Copaxone (Glatiramer acetate)
Sponsor
Kaplan Medical Center